Status:
RECRUITING
VR Homework Exercises for Selective Mutism Treatment
Lead Sponsor:
Luuk Stapersma
Conditions:
Selective Mutism
Anxiety Disorder of Childhood
Eligibility:
All Genders
4-13 years
Phase:
NA
Brief Summary
Selective mustism (SM) is an anxiety disorder that manifests in childhood. Children with Children with SM do not speak in certain social situations where this is expected of them. For example, a child...
Detailed Description
The treatment in this study consists of behavioral therapy for SM (with the protocol 'Talking at school, a matter of doing') with the addition of the VR homework exercises. The protocol consists of 10...
Eligibility Criteria
Inclusion
- The child meets the DSM-5 criteria for SM (as a primary classification).
- The child is attending primary school.
- Referred to an academic center for Child and Adolescent Psychiatry (Levvel) for diagnosis and treatment of SM
- Psychiatric comorbidity is permitted, given that SM is the primary treatment target.
- Medication use is permitted, if stable for at least 4 weeks prior to the start of treatment.
Exclusion
- No participating parents.
- Parents do not have sufficient mastery of the Dutch language.
- Parents or child have an estimated IQ below 75.
- The child needs inpatient treatment.
- Children with a (medical) condition that is a contraindication for using a VR headset (epilepsy, claustrophobia, facial condition, sensitive vestibular system, panic attacks)
- Parents receiving parental guidance which is not part of the standard treatment program.
- Children that have received protocolled behavior therapy for SM in the past 12 months.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06882629
Start Date
March 1 2025
End Date
June 1 2027
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Levvel
Amsterdam, North Holland, Netherlands, 1076 EC